Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

Background: Although non-vitamin K antagonist oral anticoagulants (NOACs) are recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management, direct long-term head-to-head comparisons are lacking. Therefore, their risk-benefit profiles were investigated compared to VKAs and bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Grymonprez, Maxim, De Backer, Tine L., Bertels, Xander, Steurbaut, Stephane, Lahousse, Lies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932194/
https://www.ncbi.nlm.nih.gov/pubmed/36817122
http://dx.doi.org/10.3389/fphar.2023.1125576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932194/
https://www.ncbi.nlm.nih.gov/pubmed/36817122
http://dx.doi.org/10.3389/fphar.2023.1125576

Ejemplares similares